Specialty Hub services providers have paralleled the growth of specialty pharmaceuticals and have played a major role in managing the increasing complexity of its use. The market for specialty hub services has grown in complexity and continues to evolve as industry stakeholders work to develop successful strategies.
Specialty medications often require extra support in order to be successful; therefore, healthcare providers, pharmacists, customers, and pharmaceutical manufacturers are in search of smart solutions to provide better service. Since, a number of the new drugs in the market have more complex routes of administration; hub provider support services have emerged to help streamline the process.
Hub service providers often play an integral role in the commercialization process of specialty drugs. These companies continue to offer significant patient and manufacturer support to help ensure patient adherence and support. Increasingly, hub service providers are expanding their capabilities by acquiring companies that will increase their importance in the commercialization process.
Hub service providers are often the main point of contact between manufacturers and the patients for these drugs. By providing complete services, the goal of the hub service provider is to streamline the patient journey. Manufacturers may offer patient support hub services internally but often find they can be better served by working with independent hub service providers and their extensive range of services and expertise.
AMI’s Specialty Hub Services Providers 2022 Report, with more than 200 pages, has expanded to include 65 Hub services providers. The report includes comprehensive information on hub providers’ solutions and services as industry stakeholders are increasingly interested in identifying the expertise offered by market participants.
Each Specialty Hub provider profile in this year’s report includes: address, phone, website, executive leadership, company background, financial performance or investor information, comprehensive intelligence on solutions and services, customer and recent activities.
As the leading source for intelligence on hub service providers, AMI offers research that addresses the markets’ needs, preferences and expectations, and designs custom projects and provides results that helps you understand how to address the market.
Table of Contents
Introduction
- Specialty Pharmaceuticals Background – ps. 5-7
- Hub Services Background – pgs. 7-8
Company Profiles
- AcariaHealth – pgs. 10-11
- Accenture Life Sciences – pgs. 12-14
- AliviaHub – pgs. 15-16
- AllazoHealth – pgs. 17-18
- AllCare Plus Pharmacy/IQVIA – pgs. 19-22
- Amalgam Rx – pgs. 23-24
- AmerisourceBergen (Lash Group/US Bioservices/Cubixx) – pgs. 25-31
- Amplity Health – pgs. 32-34
- Annexus Health – pgs. 35-36
- AnovoRx – pgs. 37-40
- AppianRx – pgs. 41-43
- Asembia – pgs. 44-46
- Ashfield Healthcare – pgs. 47-49
- AssistRx – pgs. 50-55
- Capgemini Invent (LiquidHub) – pgs. 56-58
- Cardinal Health Sonexus – pgs. 59-62
- CareMetx, LLC – pgs. 63-66
- Claritas Rx – pgs. 67-68
- Conduent Pharmaceuticals and Life Sciences – pgs. 69-71
- ConnectiveRx – pgs. 72-75
- CoPilot Provider Support Services – pgs. 76-78
- Diligent Health Solutions/Uniphar plc – pgs. 79-81
- DrFirst – pgs. 82-83
- eMAX Health Systems, LLC – pgs. 84-86
- Envision Pharma Group/ Two Labs Pharma Services – pgs. 87-90
- EVERSANA – pgs. 91-96
- Fishawack Health – pgs. 97-99
- HarborPath Direct – pgs. 100-101
- HealthConnexx LLC – pgs. 102-103
- Helio Health Group – pgs. 104-105
- Human Care Systems – pgs. 106-108
- ICON plc – pgs. 109-111
- IntegriChain – pgs. 112-114
- KloudScript – pgs. 115-117
- KnippeRx – pgs. 118-119
- Labcorp Drug Development – pgs. 120-122
- Maxor Specialty Pharmacy – pgs. 123-124
- Medvantx – pgs. 125-126
- Monarch Specialty Group – pgs. 127-128
- Occam Health Services – pgs. 129-131
- Optime Care – pgs. 132-133
- OptimizeRx – pgs. 134-136
- Optum Life Sciences – pgs. 137-138
- Orsini Specialty Pharmacy – pgs. 139-140
- P5Connect – pgs. 141-143
- PharmaCord LLC – pgs. 144-147
- Pharmspective – pgs. 148-150
- Phil, Inc. – pgs. 151-152
- Precision Value & Health – pgs. 153-156
- ProPharma Group – pgs. 157-158
- QPharma, Inc. – pgs. 159-161
- RAREiTI – pgs. 162-163
- RareMed Solutions – pgs. 164-166
- RIS Rx – pgs. 167-168
- RxCrossroads/CoverMyMeds – pgs. 169-173
- RxLightning – pgs. 174-175
- Surescripts – pgs. 176-177
- Syneos Health – pgs. 178-181
- Thrifty White – pg. 182
- TrialCard – pgs. 183-186
- Trinity Life Sciences – pgs. 187-191
- Truax Patient Services – pgs. 192-194
- Trupill – pgs. 195-197
- Truveris – pgs. 198-199
- United BioSource LLC (UBC) – pgs. 200-202
- VMS Biomarketing – pgs. 203-204